Home
Headlines & Research Highlights
TRIUMF launches new Five-Year Plan 2020-2025
09 October 2018
Designed to maximize impact, build on existing strengths, and capitalize on emerging opportunities, TRIUMF’s Five-Year Plan 2020-2025 lays out a vision for Canada’s particle accelerator centre for the next five years and the decades beyond
TRIUMF hyped by major neutrino project announcement
02 October 2018
Neutrino physics researchers at TRIUMF and around the world welcome new signals of support for planned Hyper-K detector
TRIUMF and CNL to form strategic partnership to enable ground-breaking cancer treatment
27 September 2018
Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer
New documentary highlights TRIUMF’s role in producing promising radioisotope for cancer treatment
12 September 2018
A new short documentary, The Rarest Drug on Earth, is delving into the possibility for TRIUMF to take up the reins as the world’s largest producer of actinium-225.
Award-winning TRIUMF graduate student prepares for LHC ‘glow up’
31 August 2018
With a Mitacs award win under his belt, TRIUMF graduate student, Vanier scholar, and UBC Ph.D. candidate Sébastien Rettie is embarking for the Weizmann Institute of Science to work on upgrades for ATLAS' New Muon Small Wheels system.
